FDA Ratchets Up Overseas Inspections For FY 2010 - 924 For Drug Activities
Executive Summary
FDA expects to increase its oversight of overseas pharmaceutical company activities by one-third in fiscal 2010 as it doubles the total number of foreign inspections it conducts